Ionis Pharmaceuticals IONS Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's accumulated depreciation?
- Ionis Pharmaceuticals (IONS) reported accumulated depreciation of $109.08M in Q4 2025.
- What does accumulated depreciation mean?
- The total amount of depreciation taken on physical assets over their lifetime.
- How do you interpret accumulated depreciation?
- A high ratio of accumulated depreciation to gross PPE suggests aging assets that may require significant future capital expenditure for replacement or upgrades.
- How does accumulated depreciation compare across companies?
- Commonly used across all capital-intensive industries to assess the age and remaining utility of the asset base.